Syndax Pharmaceuticals SNDX Other Receivables
Other Receivables at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherReceivables.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's other receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's other receivables?
- Syndax Pharmaceuticals (SNDX) reported other receivables of $267K in Q1 2026.
- How has Syndax Pharmaceuticals's other receivables changed year-over-year?
- Syndax Pharmaceuticals's other receivables decreased by 92.6% year-over-year, from $3.59M to $267K.
- What does other receivables mean?
- This represents miscellaneous claims for cash or other assets not classified under standard trade accounts receivable. It often includes tax refunds, interest receivables, or non-core operational claims. Monitoring this helps identify potential hidden liquidity issues or delays in cash conversion.